Indian Biopharma Valued At $350M In Funding Rounds
The biopharmaceutical division of India's Strides Pharma Science Ltd. said Friday it's now valued at $350 million after the closing of two funding rounds and that it will use the proceeds...To view the full article, register now.
Already a subscriber? Click here to view full article